Perflutren Protein-Type A Microspheres: Clinical Trials

6 trials of Perflutren Protein-Type A Microspheres, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 withdrawn. 3 Phase 2, 2 Phase 1, 1 Early Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 12Completed 2
Early Phase 11Withdrawn 1
Phase 41Completed 1

Follow Perflutren Protein-Type A Microspheres: new trials by email Literature Review of Perflutren Protein-Type A Microspheres trials Research Report on Perflutren Protein-Type A Microspheres

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema
Lumason, Optison, Definity - Lymphedema Arm
Phase 1CompletedMayo Clinic102022-12-152024-08-21
Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment
Perflutren Protein-Type A Microspheres, Contrast-Enhanced Ultrasound - Intrahepatic Cholangiocarcinoma
Phase 2CompletedThomas Jefferson University162021-12-142025-10-28
Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer
Yttrium-90 Microsphere Radioembolization, Perflutren Protein-Type A Microspheres, Dynamic Contrast-Enhanced Ultrasound Imaging - Hepatocellular Carcinoma
Phase 2CompletedThomas Jefferson University1042017-07-012026-01-02
CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children
OPTISON - Vesico-Ureteral Reflux
Phase 1 / Phase 2CompletedKassa Darge312014-07-012018-11-27
Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage
Optison echocardiography contrast agent - Atrial Fibrillation
Phase 4CompletedUniversity of Utah1002013-06-012019-08-20
Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery
Perflutren Protein-Type A Microspheres, Dynamic Contrast-Enhanced Ultrasound Imaging - Renal Cell Carcinoma
Early Phase 1WithdrawnSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2013-01-242025-05-02

Conditions studied

Atrial Fibrillation (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Renal Cell (1)  ·  Cholangiocarcinoma (1)  ·  Stroke (1)  ·  Vesico-Ureteral Reflux (1)

Sponsors

Thomas Jefferson University (2)  ·  Kassa Darge (1)  ·  Mayo Clinic (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  University of Utah (1)

Countries

United States (6)

Top investigators

Brent D Wilson, MD, PHD (1)  ·  Christine Lee, MD, PhD (1)  ·  Flemming Forsberg, PhD (1)  ·  John Eisenbrey, PhD (1)  ·  Kassa Darge, MD, PhD (1)

Results publications

PMID 41025990

NIH funding

R01CA238241 (1), R21CA259750 (1)